-
Founded in:
1991-07-11 -
Country:
China -
Address:
No. 26, Xingang Avenue, Nanjing Economic and Technological Development Zone -
Tax NO.:
91320192134908655F -
Registered Funds:
200.8 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sucralfate |
Extract from the above information
More
Extract from the above information |
54182-58-0 | 22 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| ±-ζ-(2,4,5-trimethyl-3,6-dicarbonyl-1,4-cyclohexadien-1-yl)phenylheptanoic acid |
This product is a thromboxane A2 receptor antagonist, which can inhibit the vasoconstriction reaction caused by various chemical transmitters (thromboxane A2, leukotriene D4, platelet activating factor), inhibit the immediate and delayed allergic reactions induced by antigen inhalation, and improve lung function.
More
This product is a thromboxane A2 receptor antagonist, which can inhibit the vasoconstriction reaction caused by various chemical transmitters (thromboxane A2, leukotriene D4, platelet activating factor), inhibit the immediate and delayed allergic reactions induced by antigen inhalation, and improve lung function. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Oxaliplatin |
It is a new platinum derivative. The central platinum atom is surrounded by oxalic acid and 1,2-diaminocyclohexane, presenting a trans conformation, and is a stereoisomer. It acts on DNA by producing alkylated conjugates, forming intra-chain and inter-chain crosslinks, thereby inhibiting DNA synthesis and replication. It binds to DNA rapidly, taking up to 15 minutes. DNA synthesis during replication, subsequent DNA separation, RNA and cell protein synthesis are all inhibited. Oxaliplatin treatment is effective in some cell lines that are resistant to cisplatin.
More
It is a new platinum derivative. The central platinum atom is surrounded by oxalic acid and 1,2-diaminocyclohexane, presenting a trans conformation, and is a stereoisomer. It acts on DNA by producing alkylated conjugates, forming intra-chain and inter-chain crosslinks, thereby inhibiting DNA synthesis and replication. It binds to DNA rapidly, taking up to 15 minutes. DNA synthesis during replication, subsequent DNA separation, RNA and cell protein synthesis are all inhibited. Oxaliplatin treatment is effective in some cell lines that are resistant to cisplatin. |
61825-94-3 | 56 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sucralfate |
This product can form a thin film on the surface of damaged gastric mucosa, thereby resisting the invasion of gastric acid on the mucosa and protecting the gastric mucosa. In addition, sucralfate can absorb pepsin and neutralize gastric acid, but the effect is weak.
More
This product can form a thin film on the surface of damaged gastric mucosa, thereby resisting the invasion of gastric acid on the mucosa and protecting the gastric mucosa. In addition, sucralfate can absorb pepsin and neutralize gastric acid, but the effect is weak. |
54182-58-0 | 22 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clodronate disodium Salt |
This product is a bone metabolism regulator that can enter the hydroxyapatite crystals in the bone matrix. When osteoclasts dissolve the crystals, the drug is released, which can inhibit the activity of osteoclasts and indirectly inhibit bone resorption through osteoblasts.
More
This product is a bone metabolism regulator that can enter the hydroxyapatite crystals in the bone matrix. When osteoclasts dissolve the crystals, the drug is released, which can inhibit the activity of osteoclasts and indirectly inhibit bone resorption through osteoblasts. |
22560-50-5 | 0 |